Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects
Authors:
- 18 November 2014
- journal article
- research article
- Published by Wiley in Clinical Obesity
- Vol. 5 (1) , 42-47
Abstract
Summary: Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study ofCrohn's disease (CD). We appliedASCAin relation to obesity. This study aims (i) to determine the concentration ofASCA(immunoglobulinA[IgA] and immunoglobulinG[IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation betweenASCAconcentrations, obesity indices andC‐reactive protein. Forty obese individuals (body mass index [BMI] > 35 kg m−2) and 18 healthy (BMI < 25 kg m−2) volunteers participated in this case–control study. Binding activity of serumIgAandIgGto the cell wall mannan ofS. cerevisiaewas measured by enzyme‐linked immunosorbent assay. More than one‐third of the obese individual (35%) showed elevated titres ofASCAcompared with the control group (5%). This antibody was positively associated with weight (P = 0.01),BMI(P = 0.02) and waist circumference (P = 0.02), but not withC‐reactive protein. It seems thatASCAare not only specific forCDbut are also associated with obesity.S. cerevisiaeor a related antigen may play a role in the matrix of this complex condition.Keywords
This publication has 35 references indexed in Scilit:
- Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial ResidentsPLOS ONE, 2013
- Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese MicePLOS ONE, 2012
- Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?Journal of Obesity, 2012
- Gut microbiome, obesity, and metabolic dysfunctionJournal of Clinical Investigation, 2011
- Is Obesity a Risk Factor for Crohn’s Disease?Digestive Diseases and Sciences, 2011
- Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?PLOS ONE, 2010
- The Role of Probiotics in the Poultry IndustryInternational Journal of Molecular Sciences, 2009
- Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and PerspectivesDigestive Diseases and Sciences, 2008
- Role of yeast cell wall polysaccharides in pig nutrition and health protectionLivestock Science, 2007
- Lymphocyte Proliferation Response to Baker’s Yeast in Crohn’s DiseaseDigestion, 1994